A comparative study of efficacy of drinking water on declining the incidence of nausea after administration of Teriparatide acetate

A randomized comparative study between the parallel group to evaluate the efficacy of drinking some water immediately before the administration of Teriparatide acetate for preventing the incidence of nausea - A comparative study of efficacy of drinking water on declining the incidence of nausea after administration of Teriparatide acetate

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037146

Enrollment

Registered

2019-08-01

Start date

2019-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

In this study, we randomly divide the patients who are diagnosed primary osteoporosis into two groups to treat with teriparatide acetate. In one group (25 of 50 cases), patients let be drank a cup of

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1)Female 2)Over 65 years old 3)Out patients 4)Primary osteoporosis with high risks of fragile fracture 5)Patients with sufficient informed consent to participate this study

Exclusion criteria

Exclusion criteria: 1)Patients with contraindication for the administration of teriparatide acetate 2)Patients who cannot drink a water orally 3)Patients who already had finished 104 times of the administration of teriparatide acetate, or were administrated several times 4)Patients who refused to participate this study by sufficient information 5)Other patients who are judged inappropriate to participate this study by director of this study

Design outcomes

Primary

Measure	Time frame
The primary outcomes are the incidence of nausea after the administration of Teriparatide acetate.	—

Secondary

Measure	Time frame
The secondary outcomes are the change of blood pressures immediately after administration of Teriparatide acetate and persistence rate of the administration.	—

Countries

Japan

Contacts

Public ContactYusuke Ueda

Kansai medical university, Kori Hospital Department of Orthopedic surgery

uedayu@kouri.kmu.ac.jp072-832-5321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026